Down-regulation of transforming growth factor-α by tamoxifen in human breast cancer
Open Access
- 1 July 1993
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroidsThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Epidermal and transforming growth factor α in patients with breast tumoursBritish Journal of Cancer, 1989
- Regulation of Transforming Growth Factor α and Transforming Growth Factor β Messenger Ribonucleic Acid Abundance in T-47D, Human Breast Cancer CellsMolecular Endocrinology, 1989
- Transforming growth factor αCell, 1988
- Expression of Transforming Growth Factor α and its Messenger Ribonucleic Acid in Human Breast Cancer: Its Regulation by Estrogen and its Possible Functional SignificanceMolecular Endocrinology, 1988
- Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth FactorScience, 1986
- Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth FactorScience, 1984
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.Proceedings of the National Academy of Sciences, 1983